Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 17 Jul 2024

The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets

in Renal Pharmacology

Tongyue Yang
Qi Feng
Mingwei Shao
Mengxing Pan
Feng Guo
Yi Song
Fengjuan Huang
Zhao Linlin
Jiao Wang
Lina Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379821

3,375 views

Original Research

Published on 17 Jul 2024

THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury

in Renal Pharmacology

Jing Liu
Deepak Malhotra
Yan Ge
William Gunning
Lance Dworkin
Rujun Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430451

2,827 views
2 citations

Original Research

Published on 17 Jul 2024

Acrylamide-targeting renal miR−21a−5p/Fibrotic and miR122-5p/ inflammatory signaling pathways and the role of a green approach for nano-zinc detected via in silico and in vivo approaches

in Renal Pharmacology

Leena S. Alqahtani
Manal E. Alosaimi
Amany Abdel-Rahman Mohamed
Yasmina M. Abd-Elhakim
Tarek Khamis
Ahmed E. Noreldin
Ali H. El-Far
Badriyah S. Alotaibi
Mohammed Ageeli Hakami
Naief Dahran

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413844

2,845 views
2 citations

Review

Published on 17 Jul 2024

Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022

in Renal Pharmacology

Wenchao Xu
Zitong Chen
Yurong Zhang
Jiayu Zhao
Wenyong Huang
Xiao Guo
Jianyu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388641

2,420 views
4 citations

Original Research

Published on 15 Jul 2024

Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury

in Renal Pharmacology

Xinyao Luo
Weijian Zhou
Dingyuan Wan
Jing Peng
Ruoxi Liao
Baihai Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409654

3,195 views

Review

Published on 10 Jul 2024

Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis

in Renal Pharmacology

Song Ren
Yurong Zhao
Jingyu Wu
Shangqing Ren
Yunlin Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406588

2,655 views
2 citations

Original Research

Published on 09 Jul 2024

Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway

in Renal Pharmacology

Jie Qu
Hui Pei
Xin-Ze Li
Yan Li
Jian-Ming Chen
Min Zhang
Zhong-Qiu Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414918

3,049 views
2 citations

Original Research

Published on 04 Jul 2024

De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease

in Renal Pharmacology

Maxime Pluquet
Marie Metzger
Christian Jacquelinet
Christian Combe
Denis Fouque
Maurice Laville
Luc Frimat
Ziad A. Massy
Sophie Liabeuf
Solène M. Laville

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375838

2,113 views
1 citation

Original Research

Published on 01 Jul 2024

Bibliometric and visual analysis of immunisation associated with acute kidney injury from 2003 to 2023

in Renal Pharmacology

Ling Chen
Jing Hu
Jianrao Lu
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388527

2,531 views
1 citation

Original Research

Published on 28 Jun 2024

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

in Renal Pharmacology

David A. Vesey
Abishek Iyer
Evan Owen
Danielle Kamato
David W. Johnson
Glenda C. Gobe
David P. Fairlie
David J. Nikolic-Paterson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382094

2,329 views
2 citations

Systematic Review

Published on 25 Jun 2024

Influence of sodium/glucose cotransporter-2 inhibitors on the incidence of acute kidney injury: a meta-analysis

in Renal Pharmacology

Qian Wang
Jianmin Yu
Weizhu Deng
Chao Liu
Jian Yang
Yaqing Li
Guangyan Cai
Xiangmei Chen
Zheyi Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372421

2,307 views
2 citations

Original Research

Published on 21 Jun 2024

A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system

in Renal Pharmacology

Jingyi Zhang
Yuting Guo
Chunyan Wei
Yu Yan
Huifang Shan
Bin Wu
Fengbo Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363501

2,435 views
2 citations

Original Research

Published on 19 Jun 2024

Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics

in Renal Pharmacology

Xiangmeng Li
Shimin Jiang
Xia Gu
Xiaojing Liu
Shunlai Shang
Jiao Zhang
Keying Pang
Wenge Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380326

2,664 views
4 citations

Original Research

Published on 12 Jun 2024

SGLT2i treatment during AKI and its association with major adverse kidney events

in Renal Pharmacology

Luz Alcantar-Vallin
Jose J. Zaragoza
Bladimir Díaz-Villavicencio
Karla Hernandez-Morales
Jahir R. Camacho-Guerrero
Miguel A. Perez-Venegas
Edgar J. Carmona-Morales
Alexa N. Oseguera-Gonzalez
Cesar Murguia-Soto
Gael Chávez-Alonso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356991

4,354 views
1 citation

Original Research

Published on 10 Jun 2024

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study

in Renal Pharmacology

Jian-Chun Li
Shi-Tao Huang
Fei Feng
Lin-Jun Wang
Ting-Ting Chen
Min Li
Li-Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389354

3,346 views
1 citation

Review

Published on 07 Jun 2024

Targeting pyruvate kinase M2 for the treatment of kidney disease

in Renal Pharmacology

Dan-Qian Chen
Jin Han
Hui Liu
Kai Feng
Ping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376252

5,054 views
4 citations